Visceral Adiposity and Diabetes: Translating Form to Function Using Imaging
Status:
Completed
Trial end date:
2018-11-01
Target enrollment:
Participant gender:
Summary
This study is a clinical study to investigate the gluconeogenesis pathway related to visceral
adipose tissue (VAT) in obese individuals without type 2 diabetes and the effects of
empagliflozin (EMPA) on glucose homeostasis in viscerally-obese individuals using functional
studies of glycerol metabolism in hepatic gluconeogenesis using a well-validated nuclear
magnetic resonance (NMR) spectroscopy platform.
Phase:
Phase 4
Details
Lead Sponsor:
University of Texas Southwestern Medical Center
Collaborator:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)